BioLineRx (BLRX) Retained Earnings (2011 - 2025)
BioLineRx's (BLRX) quarterly Retained Earnings came in at -$1.4 million in Q4 2025, little changed year-on-year from -$1.4 million in Q4 2024, and little changed quarter-over-quarter from -$1.4 million in Q3 2025.
BioLineRx (BLRX) Retained Earnings (2011 - 2025) Analysis & Trends
BioLineRx's Retained Earnings history runs 15 years deep, the most recent figure standing at -$1.4 million for Q4 2025.
- On a quarterly basis, Retained Earnings changed 0.0% year-over-year to -$1.4 million in Q4 2025; TTM through Dec 2025 was -$1.4 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at -$1.4 million, changed 0.0% from the prior year.
- Retained Earnings steadied at -$1.4 million in Q4 2025 per BLRX's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$1.4 million in Q1 2021 and bottomed at -$1.4 million in Q1 2021.
- The 5-year median for Retained Earnings is -$1.4 million (2021), against an average of -$1.4 million.
- Biggest YoY gain for Retained Earnings was 0.0% in 2021; the steepest drop was 0.0% in 2021.
- Year by year, Retained Earnings stood at -$1.4 million in 2021, then changed by 0.0% to -$1.4 million in 2022, then changed by 0.0% to -$1.4 million in 2023, then changed by 0.0% to -$1.4 million in 2024, then changed by 0.0% to -$1.4 million in 2025.
- Per Business Quant, the three latest BLRX Retained Earnings figures stand at -$1.4 million (Q4 2025), -$1.4 million (Q3 2025), and -$1.4 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | -1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.42 Mn |
| Sep 30, 2025 | -1.42 Mn |
| Jun 30, 2025 | -1.42 Mn |
| Mar 31, 2025 | -1.42 Mn |
| Dec 31, 2024 | -1.42 Mn |
| Sep 30, 2024 | -1.42 Mn |
| Jun 30, 2024 | -1.42 Mn |
| Mar 31, 2024 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Sep 30, 2023 | -1.42 Mn |
| Jun 30, 2023 | -1.42 Mn |
| Mar 31, 2023 | -1.42 Mn |
| Dec 31, 2022 | -1.42 Mn |
| Sep 30, 2022 | -1.42 Mn |
| Jun 30, 2022 | -1.42 Mn |
| Mar 31, 2022 | -1.42 Mn |
| Dec 31, 2021 | -1.42 Mn |
| Sep 30, 2021 | -1.42 Mn |
| Jun 30, 2021 | -1.42 Mn |
| Mar 31, 2021 | -1.42 Mn |